NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters' Option to Purchase Additional December 14, 2024 Comments are off
Exclusive-Major cloud providers could get key role in AI chip access outside the US – sources December 14, 2024 Comments are off
MISTRAS Group Appoints Hani Hammad as Chief Operating Officer (COO) December 13, 2024 Comments are off
No evidence New Jersey drone sightings pose security threat, White House says December 13, 2024 Comments are off